---
title: "Bayer AG Stock 12‑Month Price Target Raised to €56.03, Implies 19% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294860516.md"
description: "Bayer AG's average 12-month price target has been raised to €56.03 by 18 analysts, up from €55.03, implying a 19% upside based on the August 3 closing price. The consensus rating remains 'Buy' among 21 covering analysts, with forecasts ranging from €46 to €65 per share."
datetime: "2026-08-04T19:20:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294860516.md)
  - [en](https://longbridge.com/en/news/294860516.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294860516.md)
generator: "portal-rs"
---

# Bayer AG Stock 12‑Month Price Target Raised to €56.03, Implies 19% Upside

-   According to estimates from 18 analysts, Bayer AG stock's average price target has risen from €55.03 to €56.03, with forecasts ranging from €46 to €65 per share
-   Based on the Aug. 3 closing price, the updated target implies approximately 19% potential upside
-   Consensus rating remains at “Buy” across 21 covering analysts, with 15 Buys, 5 Holds and 1 Sells

Explore more price target data and ratings for Bayer AG on the , and track all previous and future analyst recommendations for Bayer AG in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md)
- [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md)
- [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md)

## Related News & Research

- [Short Interest in Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Increases By 94.9%](https://longbridge.com/en/news/296026963.md)
- [Bayer says Japan approves sevabertinib for HER2-mutant NSCLC](https://longbridge.com/en/news/296745277.md)
- [MustGrow Receives First Milestone Payment from Bayer AG | MGROF Stock News](https://longbridge.com/en/news/296609006.md)
- [BAYN: Strong 2025 results, innovation focus, and €2bn cost savings drive improved financial outlook](https://longbridge.com/en/news/294831947.md)
- [Bayer Swings to Net Profit on Smaller Litigation Charges](https://longbridge.com/en/news/294778020.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**